Published in J Clin Oncol on January 15, 2003
Treatment of Chronic Anemia With Epoetin Alfa in Elderly | NCT00337441
Couple perceptions of fibromyalgia symptoms: the role of communication. Pain (2013) 1.44
Physical, emotional, and social health differences between posttreatment young adults with cancer and matched healthy controls. Cancer (2014) 1.34
Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer (2006) 1.16
Qigong improves quality of life in women undergoing radiotherapy for breast cancer: results of a randomized controlled trial. Cancer (2013) 1.14
Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro. Br J Cancer (2003) 1.12
Self-reported fatigue: one dimension or more? Lessons from the Functional Assessment of Chronic Illness Therapy--Fatigue (FACIT-F) questionnaire. Support Care Cancer (2010) 1.08
Pharmacodynamic model for chemotherapy-induced anemia in rats. Cancer Chemother Pharmacol (2007) 0.93
Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data. Br J Cancer (2014) 0.90
Trait anxiety as an independent predictor of poor health-related quality of life and post-traumatic stress symptoms in rectal cancer. Br J Health Psychol (2009) 0.86
The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia. Leuk Res (2008) 0.85
Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin. J Transl Med (2006) 0.85
A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer. Gynecol Oncol (2009) 0.84
Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancer. BMC Cancer (2012) 0.83
Age-associated differences in fatigue among patients with cancer. J Pain Symptom Manage (2010) 0.80
Cancer cachexia and anabolic interventions: a case report. J Cachexia Sarcopenia Muscle (2012) 0.80
Transfusion alert for patients with curable cancer. World J Surg (2007) 0.80
Interaction of psychological factors and the effect of epoetin-alfa treatment in cancer patients on hemoglobin and fatigue. Support Care Cancer (2006) 0.78
Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage (2012) 0.77
Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly. Support Care Cancer (2007) 0.76
Antianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort Study-The Tumor Anemia Registry. Anemia (2016) 0.75
Managing anemia in lymphoma and multiple myeloma. Ther Clin Risk Manag (2008) 0.75
Factors Associated with Fatigue in Korean Gastric Cancer Survivors. Korean J Fam Med (2015) 0.75
Clinical validity of the Japanese version of the Functional Assessment of Cancer Therapy-Anemia Scale. Support Care Cancer (2006) 0.75
Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med (2009) 5.36
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial. Lancet (2011) 2.88
Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer. J Clin Oncol (2010) 2.61
External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer. J Natl Cancer Inst (2014) 2.26
Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysis. J Clin Oncol (2013) 2.17
Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis. Eur J Cancer (2012) 2.07
Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol (2005) 2.06
Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA (2012) 2.00
Premature ejaculation: results from a five-country European observational study. Eur Urol (2007) 1.79
Unfavourable pattern of metastases in M0 breast cancer patients during 1978-2008: a population-based analysis of the Munich Cancer Registry. Breast Cancer Res Treat (2011) 1.70
Erythropoietin improves quality of life. Lancet Oncol (2002) 1.41
Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor. PLoS One (2010) 1.40
Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. Cancer Res (2013) 1.28
Phase I pharmacokinetic and pharmacodynamic study of the aurora kinase inhibitor danusertib in patients with advanced or metastatic solid tumors. J Clin Oncol (2009) 1.26
Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia. Psychiatry Res (2008) 1.25
Clinical implications of CYP2D6 genotyping in tamoxifen treatment for breast cancer. Clin Cancer Res (2009) 1.14
Prognostic significance of geriatric assessment in combination with laboratory parameters in elderly patients with aggressive non-Hodgkin lymphoma. Leuk Lymphoma (2015) 1.13
Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia. Curr Med Res Opin (2009) 1.12
The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practice. BJU Int (2008) 1.11
The psychological burden of premature ejaculation. J Urol (2007) 1.11
Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: an update of recent developments. Ann Surg Oncol (2006) 1.07
Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partners. J Urol (2007) 1.03
Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy. Eur J Cancer (2013) 0.98
The economics of blood: gift of life or a commodity? Int J Technol Assess Health Care (2006) 0.96
Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol (2013) 0.96
The effect of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial: a meta-analysis of the US, German, Netherlands, and Belgium sub-studies. J Cancer Res Clin Oncol (2010) 0.95
Interleukin-6/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancer. Curr Pharm Des (2012) 0.94
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha. Cancer Immunol Immunother (2011) 0.92
Experiences with the FACT-EGFRI-18 instrument in EGFRI-associated mucocutaneous adverse events. Support Care Cancer (2013) 0.92
Stick Together: A Nordic Walking Group Intervention for Breast Cancer Survivors. J Psychosoc Oncol (2015) 0.91
Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma. J Cancer Res Clin Oncol (2012) 0.90
Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist (2013) 0.88
Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan. Clin Cancer Res (2005) 0.88
From despair to hope: a longitudinal study of illness perceptions and coping in a psycho-educational group intervention for women with breast cancer. Br J Health Psychol (2012) 0.87
Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia Survey. Oncology (2006) 0.87
Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients. Eur J Cancer (2008) 0.87
Guidelines-based diagnostic process does increase hospital delay in a cohort of colorectal cancer patients: a population-based study. Eur J Cancer Prev (2014) 0.86
Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics. Int J Clin Pharm (2011) 0.85
Development and validation of the Diabetic Foot Ulcer Scale-short form (DFS-SF). Pharmacoeconomics (2003) 0.84
Independent effect of paliperidone extended release on social functioning beyond its effect on positive and negative symptoms of schizophrenia: a mediation analysis. J Clin Psychopharmacol (2009) 0.84
Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial. Breast Cancer Res Treat (2014) 0.84
Timing of fertility preservation procedures in a cohort of female patients with cancer. Eur J Obstet Gynecol Reprod Biol (2011) 0.83
Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases. Ann Surg Oncol (2008) 0.82
Translation and linguistic validation of the FACT-EGFRI-18 quality of life instrument from English into Dutch. Eur J Oncol Nurs (2013) 0.81
Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation. Am J Hematol (2014) 0.81
The role of bevacizumab in advanced epithelial ovarian cancer. Curr Pharm Des (2012) 0.79
Translation and validation of EORTC QLQ-C30 into Indonesian version for cancer patients in Indonesia. Jpn J Clin Oncol (2011) 0.78
Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancer. Pharmacoeconomics (2003) 0.78
CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial. Breast Cancer Res Treat (2013) 0.78
Impact of chemotherapy-induced nausea and vomiting on quality of life in indonesian patients with gynecologic cancer. Int J Gynecol Cancer (2012) 0.78
Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: a Dutch TEAM trial analysis. Acta Oncol (2014) 0.77
Personal and social functioning in schizophrenia: defining a clinically meaningful measure of maintenance in relapse prevention. Curr Med Res Opin (2010) 0.77
Severe colitis while responding to ipilimumab in metastatic melanoma. Acta Oncol (2012) 0.77
Oncologists' practice and attitudes regarding fertility preservation in female cancer patients: a pilot study in the Netherlands. J Psychosom Obstet Gynaecol (2013) 0.77
NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis. Oncol Res Treat (2015) 0.76
Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors. Invest New Drugs (2009) 0.76
A multigene RT-PCR assay used to predict recurrence in early breast cancer: two presentations with contradictory results. Breast Cancer Res (2004) 0.75
Clinical significance of patient-reported questionnaire data: two more steps? J Clin Epidemiol (2006) 0.75
In vitro schedule-dependent interaction between melphalan and oxaliplatin in human colorectal cancer cell lines. J Surg Res (2009) 0.75
The cost effectiveness of two new antiepileptic therapies in the absence of direct comparative data: a first approximation. Pharmacoeconomics (2003) 0.75
The prognostic relevance of the mitotic activity index in axillary lymph node-negative breast cancer. Breast Cancer Res Treat (2014) 0.75